Show Notes
What actually happened inside the DEA’s cannabis rescheduling hearing? In this timely episode of the Bioactive Podcast, Dr. Riley Kirk sits down with Max Jackson, former commercial cannabis cultivator and founder of Cannabis Wise Guys, to unpack what he witnessed firsthand at the DEA hearing on moving cannabis from Schedule I to Schedule III.
Max spent most of the hearing inside the room, taking handwritten notes because recording and livestreaming were not permitted. As someone who previously managed a commercial cultivation facility with approximately 13,000 flowering cannabis plants, he offers a unique perspective on the arguments being made about cannabis, medical use, public health, research, and the plant itself.
Together, Riley and Max break down who opposed rescheduling, what the government and opposing parties argued, and some of the surprising claims and misconceptions that came up during the proceedings. They discuss the difference between whole-plant cannabis and isolated cannabinoids, the challenges of dosing and medical education, cannabis research limitations, adverse effects, and why the lack of cannabis research is itself connected to decades of Schedule I restrictions.
The conversation also explores what rescheduling to Schedule III could actually mean, what happens next in the process, why the administrative judge does not make the final decision, and why the DEA ultimately holds that decision.
Whether you're a cannabis consumer, home grower, medical professional, researcher, cultivator, cannabis business owner, or simply trying to understand the future of cannabis policy in the United States, this episode gives you an inside look at a hearing most people never had the opportunity to see.
CHAPTERS:
00:00 Welcome and Guest Intro
00:40 Max Jackson Background
01:36 Why He Attended Hearing
02:52 Security and Closed Doors
06:46 Who Opposed Rescheduling
08:18 Bias and Expert Framing
10:58 Psychosis and CUD Claims
17:08 IV THC and Syringe Confusion
19:16 Plant vs Single Molecule
23:36 No Medical Use Argument
26:45 Youth Access and Regulation
31:13 Humboldt Crime Fears
33:07 Hearing Strategy Angle
33:57 Drugged Driving Testing
35:50 Tolerance And Impairment
38:30 Research Collaboration Gaps
41:10 Breastfeeding And Postpartum
42:54 ER Harms And Education
45:48 Schedule Logic Debate
51:21 DEA Museum Narrative
54:26 Van Check At DEA
57:49 What Happens Next
59:27 Wrap Up And Resources
Connect with Max Jackson
Cannabis Wise Guys
Cannabis Fact Book
https://thecannabisfactbook.com/
Email: [email protected]
IG: www.instagram.com/cannabiswiseguys/
Want Exclusive Content and ad-free episodes?
Join the Bioactive Patreon community for as little as $1/month to ask guests your burning
questions, access exclusive content, and connect with Dr. Kirk one-on-one.
www.Patreon.com/Cannabichem
Don’t forget to like, subscribe, and hit the notification bell for more expert insights into
cannabis science, plant biology, and more!
Sign Up for Emails!
www.AppliedPharmacognosy.org
Keep up with Dr. Riley Kirk:
https://www.bioactivepodcast.com/
https://www.youtube.com/@cannabichem
https://instagram.com/cannabichem
https://www.appliedpharmacognosy.org/ Learn more about your ad choices. Visit megaphone.fm/adchoices
More from BIOACTIVE
What are cannabis terpenes, how do they influence aroma and consumer experiences, and what do we know about their safety? On this episode of the Bioactive Podcast, Dr. Riley Kirk sits down with Dr. Shawna Vreeke, PhD, DABT, Head of Toxicology at True Terpenes, to explore the science of cannabis terpenes, terpene chemistry, cannabinoid interactions, and consumer safety. With a PhD in Chemistry focused on toxin formation in vape device aerosols and expertise in toxicology risk assessment, Shawna shares insights into what current research tells us about terpenes and where important questions remain unanswered.
Dr. Riley Kirk welcomes Dr. Miyabe Shields for a deep dive into cannabis real-world data, cannabis consumption patterns, dosing, neurodivergent cannabis use, and the Endocannabinoid System (ECS). As co-founders of the Network of Applied Pharmacognosy (NAP), Riley and Miyabe discuss the newly accessible Real Data Project, including what large-scale consumer data can reveal about how people actually use cannabis in their everyday lives.
What if carbon is one of the most overlooked inputs in plant nutrition? In this episode of the Bioactive Podcast, Dr. Riley Kirk sits down with Nik Nikolayev, CEO of Rooted Leaf Agritech, to explore the science of carbon-based fertilizers, plant nutrition, biostimulants, organic acids, and the chemistry behind plant growth, yield, and quality.
Dr. Riley Kirk has Dr. Denise Valenti on the podcast to discuss cannabis and driving, cannabis impairment, THC testing, and the challenges of determining whether someone is actually too impaired to drive. They explore why THC levels in the body do not necessarily correspond to impairment and how cannabis can affect vision, peripheral vision, contrast sensitivity, eye movement, balance, and pupil response.
In this episode of the Bioactive Podcast, Dr. Riley Kirk sits down with Dr. Rick Pescatore, board-certified emergency physician, Editor-in-Chief of Emergency Medicine News, and founder of BellyMD, for a fascinating deep dive into the gut-brain connection and what it means for cannabis users and patients dealing with unexplained digestive symptoms.